Approval · Notice of Compliance 8674 · 2007
SPRIAFIL: Notice of Compliance 8674
Issued March 26, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8674
- Date
- March 26, 2007
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antifungal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPRIAFIL | 02293404 | Marketed |
Medicinal ingredients
- POSACONAZOLE 40 MG per ML